Literature DB >> 22308907

Conservative surgery for borderline ovarian tumors--emphasis on fertility preservation. A review.

N Koutlaki1, M Dimitraki, S Zervoudis, V Sofiadou, X Grapsas, A Psillaki, I Nikas, G Galazios, V Liberis, S Voiculescu, T Burcoş.   

Abstract

BACKGROUND: Borderline ovarian tumors account for 15-20% of all ovarian epithelial tumors. Since their original description in 1929, our knowledge of their natural history and molecular pathology has advanced most dramatically over the last two decades. This improved knowledge of BOT has permitted to drastically decrease the therapeutics of these tumors, which remains mostly surgical.
METHOD: We studied the available literature on surgical management of BOT accentuating the most important aspects on this topic: radical vs. conservative treatment, fertility preservation.
RESULTS: Although there are conflicting reports about some of the aspects of surgical management of these tumors, since BOTs commonly affect women of reproductive age, who have not completed childbearing, have an excellent overall prognosis and the majority of them (approximately 50% to 85%) are stage I at diagnosis, conservative surgery (unilateral salpingo-oophorectomy or cystectomy) can be safely performed after comprehensive surgical staging, in order to preserve fertility.
CONCLUSION: Conservative surgery could be safely performed in young patients treated for BOT, provided that they are carefully followed-up.

Entities:  

Mesh:

Year:  2011        PMID: 22308907

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  1 in total

1.  Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.

Authors:  Rie Mimura; Fumi Kato; Khin Khin Tha; Kohsuke Kudo; Yosuke Konno; Noriko Oyama-Manabe; Tatsuya Kato; Hidemichi Watari; Noriaki Sakuragi; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2016-01-21       Impact factor: 2.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.